Providing new treatment opportunities for all patients while advancing scientific knowledge through clinical trials. Experience and dedication you can trust.

Study Name

ACR-368-201/GOG-3082

Study Title

A Phase 1b/2 Basket Study of ACR-368 as Monotherapy and in Combination with Gemcitabine in Adult Subjects with Platinum-Resistant Ovarian Carcinoma, Endometrial Adenocarcinoma, and Urothelial Carcinoma Based on Acrivon OncoSignature® Status

Start Date

2022

Enrollment Status

Enrolling new patients

Sponsor

Acrivon Therapeutics, Inc.

Study Type

Ovarian, Endometrial and Urothelial

Location

Willis Knighton Cancer Center
2600 Kings Hwy Shreveport, LA 71103
Hidden
Main Inclusion

Subjects who are at least 18 years of age at time of consent

Subject must be able to give signed, written informed consent

 

Hidden
Exclusion Criteria

Subject has cardiovascular disease

Subject has a history of major surgery within 4 weeks of screening

Women who are pregnant

 

Hidden
Treatment Information

Subjects will be asked about any medications or treatments they have taken in the past, or are currently taking, including previous cancer treatments, prescription medications, over-the-counter medications, vitamins, herbal supplements, natural remedies, and radiation therapy. Some medications or treatments the subject has taken may make it difficult for the subject to take part in the study. All medications will have to be reviewed by the study doctor, who may ask the subject to stop some of them. The subject will also be asked about any surgical or invasive treatments they have received within the past 4 weeks. Throughout the study, the subject will be asked to report any changes in their medications or treatments, including for their cancer diagnosis.

Hidden
Costs & Stipend Details

Tests and procedures that are done only because the subject is in the study are provided at no cost. This includes:

  • Biopsy (if done only for the study)
  • OncoSignature Testing
  • Extra MRI or CT scans
  • Blood sampling for Biomarker Research and for Study Medical Measurements
  • Electrocardiograms that would not have been done if the subject were not on the study

The study drugs that are required by the study are provided at no cost to you.

The subject will not be paid for being in this study.

Hidden
General Information

The main purpose of this study is to investigate how effective the study drug is in treating ovarian carcinoma, endometrial adenocarcinoma, and urothelial carcinoma.

Ready to Participate?

Sign-up today to see if you qualify for a clinical research study. Our team is happy to discuss your options and answer any questions you may have related to eligibility for any of the research opportunities available.